Described as anti-obesity and anti-diabetic, FGF-21 and its receptor agonists improve insulin sensitivity (IS) and promote weight loss by stimulating brown fat thermogenesis and increasing release of adiponectin serum levels [27,28]. Here, ADIPOQ is linked to obesity disorder.